The biggest loser of the post position draw for Saturday's Kentucky Derby also happens to be the favorite for the 152nd ...

Official post positions and morning line odds for the 2026 Kentucky Derby. See the full field for the Saturday, May 2 race at ...

The 2026 Kentucky Derby features top thoroughbreds competing for the Triple Crown's first jewel. Here's how this year’s field ...

Time for the Friday tradition of watching the cut line for this week's PGA Tour event, right? And especially off the heels of the Masters? All eyes should be glued to the leaderboard at the second ...

Add Yahoo as a preferred source to see more of our stories on Google. A fence fell and knocked down a woman walking on what appeared to be a location shoot in downtown Brooklyn on Friday, April 10.

You haven’t actually experienced the soul of the Michigan countryside, if you aren’t currently navigating a gravel shoulder while the scent of cinnamon and fresh sawdust recalibrates your internal GPS ...

Elizabeth Hurley donned a red-hot pair of bikini bottoms to serve up an unexpected beauty secret. The supermodel was pictured on Instagram in a pair of skin-baring snapshots wearing chain-embellished ...

MIAMI (WSVN) - There’s a new cruise ship in town, and it is almost ready to set sail. Luna, Norwegian Cruise Line’s newest ship, welcomed people aboard for the very first time on Tuesday. Luna is the ...

4-time MVP LeBron James looked mortal on Monday in the first half of the Los Angeles Lakers’ game against the Detroit Pistons. Despite consistently outpacing Father Time through the years, the 41-year ...

Add Yahoo as a preferred source to see more of our stories on Google. Dallas Cowboys cheerleader performs during the game against the Washington Commanders at AT&T Stadium. Dallas Cowboys cheerleader ...

CHICAGO (WLS) -- A man was stabbed on a CTA Red Line platform in River North Thursday night, Chicago police said. The stabbing occurred at about 11:58 p.m. at the State and Grand station. Police said ...

A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.